These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32298962)

  • 1. Radiological audit of interval breast cancers: Estimation of tumour growth rates.
    MacInnes EG; Duffy SW; Simpson JA; Wallis MG; Turnbull AE; Wilkinson LS; Satchithananda K; Rahim R; Dodwell D; Hogan BV; Blyuss O; Sharma N
    Breast; 2020 Jun; 51():114-119. PubMed ID: 32298962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor volume doubling time estimated from digital breast tomosynthesis mammograms distinguishes invasive breast cancers from benign lesions.
    Sadeghipour N; Tseng J; Anderson K; Ayalasomayajula S; Kozlov A; Ikeda D; DeMartini W; Hori SS
    Eur Radiol; 2023 Jan; 33(1):429-439. PubMed ID: 35779088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands.
    Nederend J; Duijm LE; Louwman MW; Coebergh JW; Roumen RM; Lohle PN; Roukema JA; Rutten MJ; van Steenbergen LN; Ernst MF; Jansen FH; Plaisier ML; Hooijen MJ; Voogd AC
    Eur J Cancer; 2014 Jan; 50(1):31-9. PubMed ID: 24275518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
    Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
    Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
    Bailey SL; Sigal BM; Plevritis SK
    J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic features associated with interval breast cancers in screening programs.
    Boyd NF; Huszti E; Melnichouk O; Martin LJ; Hislop G; Chiarelli A; Yaffe MJ; Minkin S
    Breast Cancer Res; 2014 Aug; 16(4):417. PubMed ID: 25346388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers.
    Vitak B; Olsen KE; Månson JC; Arnesson LG; Stål O
    Eur Radiol; 1999; 9(3):460-9. PubMed ID: 10087117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Mortality Among Participants of Women's Health Initiative Trials With Screening-Detected Breast Cancers vs Interval Breast Cancers.
    Irvin VL; Zhang Z; Simon MS; Chlebowski RT; Luoh SW; Shadyab AH; Krok-Schoen JL; Tabung FK; Qi L; Stefanick ML; Schedin P; Jindal S
    JAMA Netw Open; 2020 Jun; 3(6):e207227. PubMed ID: 32602908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.
    Chen Y; Klingen TA; Wik E; Aas H; Vigeland E; Liestøl K; Garred Ø; Mæhlen J; Akslen LA; Lømo J
    Diagn Pathol; 2014 Dec; 9():230. PubMed ID: 25522915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound.
    Ryu EB; Chang JM; Seo M; Kim SA; Lim JH; Moon WK
    Eur Radiol; 2014 Sep; 24(9):2227-35. PubMed ID: 24895040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast screening: What can the interval cancer review teach us? Are we perhaps being a bit too hard on ourselves?
    Lekanidi K; Dilks P; Suaris T; Kennett S; Purushothaman H
    Eur J Radiol; 2017 Sep; 94():13-15. PubMed ID: 28941754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
    Young KC; Wallis MG; Blanks RG; Moss SM
    Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour characteristics among women with very low-risk breast cancer.
    Narod SA; Valentini A; Nofech-Mozes S; Sun P; Hanna W
    Breast Cancer Res Treat; 2012 Aug; 134(3):1241-6. PubMed ID: 22547106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.